Big Pharma

Big Pharma Has Mad Love For These 2 Biotechs
Big Pharma Has Mad Love For These 2 Biotechs
Motley Fool
Big Pharma
biotechs
Regenxbio
Denali Therapeutics
Flag link:
Big Pharma giving more money to patient advocacy groups
Big Pharma giving more money to patient advocacy groups
Beckers Hospital Review
Big Pharma
JNJ
AbbVie
Bristol-Myers Squibb
Pfizer
Merck
AstraZeneca
patient advocacy groups
Flag link:
Is CEO pay linked to drug prices? Curious investors failed their campaign to find out
Is CEO pay linked to drug prices? Curious investors failed their campaign to find out
Fierce Pharma
Big Pharma
investors
drug pricing
executive pay
Flag link:
China's driving sales growth ahead of the U.S. for Big Pharma. But can it last?
China's driving sales growth ahead of the U.S. for Big Pharma. But can it last?
Fierce Pharma
China
Big Pharma
Flag link:
In R&D, small biotechs hold their own against big pharma
In R&D, small biotechs hold their own against big pharma
Biopharma Dive
biotech
Big Pharma
R&D
Flag link:
The latest Instagram influencer frontier? Medical promotions.
The latest Instagram influencer frontier? Medical promotions.
Vox
social media
Big Pharma
pharma marketing
Flag link:
Based On Sales Forecasts For 2018 FDA Approved Drugs, Big Pharma Not Just Focused On Blockbusters
Based On Sales Forecasts For 2018 FDA Approved Drugs, Big Pharma Not Just Focused On Blockbusters
Forbes
Big Pharma
Pfizer
Merck
AstraZeneca
Gilead Sciences
Alexion
Vertex Pharmaceuticals
Flag link:
Does Johnson & Johnson's Grim Outlook Spell Trouble for Big Pharma Stocks?
Does Johnson & Johnson's Grim Outlook Spell Trouble for Big Pharma Stocks?
Motley Fool
JNJ
Big Pharma
pharma stocks
Flag link:
Which Big Pharma Stocks Lose Most in a War on Drug Price Hikes?
Which Big Pharma Stocks Lose Most in a War on Drug Price Hikes?
Yahoo/Motley Fool
drug pricing
Big Pharma
Amgen
AstraZeneca
Pfizer
GSK
Merck
Gilead
Flag link:
Big Pharma Less Concerned About Industry Disruption This Year
Big Pharma Less Concerned About Industry Disruption This Year
Forbes
Big Pharma
pharma industry
Amazon
drug pricing
Flag link:
Should You Be Worried About the Return of Big Pharma Deals?
Should You Be Worried About the Return of Big Pharma Deals?
Motley Fool
GSK
Tesaro
M&A
Big Pharma
JNJ
Argenx
Flag link:
This Big Pharma Bet Isn't Paying Off Yet
This Big Pharma Bet Isn't Paying Off Yet
Motley Fool
Big Pharma
biosimilars
Novartis
Amgen
Merck
Pfizer
Biogen
Flag link:
Big Pharma Seeks More Partnerships, Evidence in Digital Therapeutics
Big Pharma Seeks More Partnerships, Evidence in Digital Therapeutics
Xconomy
digital therapeutics
Big Pharma
Flag link:
Big pharma proves that oncology pays as workforces shrink
Big pharma proves that oncology pays as workforces shrink
EP Vantage
oncology
Big Pharma
Flag link:
Big Pharma executives jump to China startups for higher pay and more say: report
Big Pharma executives jump to China startups for higher pay and more say: report
Fierce Pharma
China
Big Pharma
Flag link:
J&J, Pfizer, Merck again lead pharma in Fortune 500
J&J, Pfizer, Merck again lead pharma in Fortune 500
Biopharma Dive
Fortune 500
Big Pharma
JNJ
Merck
Pfizer
Flag link:
Which Big Pharma CEOs Least Deserved Their Big Pay Increases?
Which Big Pharma CEOs Least Deserved Their Big Pay Increases?
Motley Fool
Big Pharma
Pharma CEOs
executive pay
AbbVie
Bristol-Myers Squibb
Gilead Sciences
JNJ
Pfizer
Flag link:
Will flush-with-cash Big Pharma beat Takeda to a Shire deal?
Will flush-with-cash Big Pharma beat Takeda to a Shire deal?
Fierce Pharma
Takeda
Shire
M&A
Big Pharma
Flag link:
Big Pharma's billion-dollar scramble to invest in start-ups to fuel innovation
Big Pharma's billion-dollar scramble to invest in start-ups to fuel innovation
CNBC
Big Pharma
innovation
start-ups
Flag link:
New Budget Deals Big Pharma a Blow on Medicare Part D, but Omeros Scores
New Budget Deals Big Pharma a Blow on Medicare Part D, but Omeros Scores
TheStreet.com
Big Pharma
Medicare Part D
Omeros
Omnibus Bill
Flag link:

Pages